ATR-dependent phosphorylation of ATRIP in response to genotoxic stress

Eisuke Itakura1, Kazuyuki Umeda, Ei Sekoguchi

  • 1Department of Geriatric Research, National Institute for Longevity Sciences, Obu, Aichi, Japan.

Insights

The ATR-ATRIP complex maintains genome integrity. ATR-dependent phosphorylation of ATRIP at Ser-68 and -72 is not essential for the DNA damage response, suggesting it

Area of Science:

  • Cellular biology
  • Molecular biology
  • Genetics

Background:

  • The ATR-ATRIP complex is crucial for maintaining genome integrity by transducing DNA damage checkpoint signals.
  • The precise mechanism of ATR kinase activation upon DNA damage remains largely unknown.

Purpose of the Study:

  • To investigate the role of ATRIP phosphorylation in the ATR-dependent DNA damage response.
  • To elucidate the kinase activation mechanism of the ATR-ATRIP complex.

Main Methods:

  • In vitro kinase assays to determine ATRIP phosphorylation sites.
  • Generation of phospho-specific antibodies for phosphorylated ATRIP.
  • Analysis of ATRIP relocalization and downstream effector activation in response to genotoxic stimuli.

Main Results:

  • ATRIP is phosphorylated in an ATR-dependent manner following genotoxic stress.
  • Serine 68 and 72 residues of ATRIP are critical for its in vivo phosphorylation by ATR.
  • Phosphorylation of ATRIP is not required for its recruitment to DNA damage foci or for the activation of downstream signaling pathways.

Conclusions:

  • ATR-mediated phosphorylation of ATRIP at Ser-68 and -72 is dispensable for the initial DNA damage response.
  • The study provides new insights into the regulation of the ATR-ATRIP complex during genome surveillance.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...